New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2013
19:17 EDTVRA, DELL, TTMI, PCRX, CBK, CRS, FIVEOn The Fly: After Hours Movers
UP AFTER EARNINGS/GUIDANCE: Vera Bradley (VRA), up 9.7% after raising its Q4, FY12 EPS views... Christopher & Banks (CBK), up 8.4% after raising its Q4 SSS view... TTM Technologies (TTMI), up 6.8% after providing Q4 EPS and revenue guidance within range of Street... DOWN AFTER EARNINGS/GUIDANCE: Five Below (FIVE), down 1.8% despite raising its Q4 guidance... Pacira Pharmaceuticals (PCRX), down 4.6% after providing Q4, FY12 revenue guidance... Carpenter Technology (CRS), down 6% after providing Q2 EPS, revenue guidance below Street estimates... ALSO LOWER: Dell (DELL), down 1.2% after CNBC's David Faber reported a buyout deal for the company would likely be worth $13.50-$14 per share.
News For VRA;CBK;TTMI;FIVE;PCRX;DELL;CRS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 27, 2015
07:27 EDTPCRXPacira price target lowered to $72 from $81 at Jefferies
Subscribe for More Information
July 20, 2015
07:31 EDTCBKChristopher & Banks responds to recent shareholder inquiry
Christopher & Banks Corporation on July 8 received a letter from the Macellum Advisors GP seeking certain of the company’s books and records in connection with transactions in our stock in 2014 by four of our directors. Subsequently, Macellum publicly disclosed that request in connection with a Schedule 13D filing. The company issued the following statement: The company is in the process of complying with the books and records demand pursuant to applicable law. The sales of CBK stock by three of the company’s directors in September 2014 questioned by Macellum were all promptly made following the company’s earnings announcement in September 2014. In each case, the trade was pre-cleared pursuant to the company’s stock trading policy. The fourth director did not sell his shares but rather transferred shares to his former spouse in accordance with the terms of his divorce decree. The company is confident that an objective review of the facts will reflect that there were no violations of law by any of these directors.
July 16, 2015
07:30 EDTFIVEFive Below management to meet with Deutsche Bank
Subscribe for More Information
July 15, 2015
16:28 EDTCRSOn The Fly: Top stock stories for Wednesday
Subscribe for More Information
12:02 EDTCRSAllegheny Technologies dives after slashing Q2 outlook, peers follow
Subscribe for More Information
08:07 EDTPCRXPacira, Aratana announce 'positive' pivotal results for AT-003 for dogs
Subscribe for More Information
07:29 EDTPCRXAmerican Orthopaedic Foot & Ankle Society to hold annual meeting
Subscribe for More Information
July 14, 2015
16:21 EDTPCRXAratana Therapeutics reports 'positive results' from pivotal study of AT-003
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use